Vanderbilt University Medical Center implemented pharmacogenomics (PGx) testing with
the Pharmacogenomic Resource for Enhanced Decisions in Care and Treatment …

Findings from pharmacogenomics (PGx) studies have the potential to be applied to
individualize drug therapy to improve efficacy and reduce adverse drug events. Researchers …

Clinical decision support (CDS) is often cited as an essential part of pharmacogenomics
(PGx) implementations. A multitude of strategies are available; however, it is unclear which …

Pharmacogenomics (PGx) is often promoted as the domain of precision medicine with the
greatest potential to readily impact everyday healthcare. Rapid advances in PGx knowledge …

Clinical decision support (CDS) is an essential part of any pharmacogenomics (PGx)
implementation. Increasingly, institutions have implemented CDS tools in the clinical setting …

Implementation of pharmacogenomics (PGx) in clinical care can lead to improved drug
efficacy and reduced adverse drug reactions. However, there has been a lag in adoption of …

Background: Despite potential benefits, the practice of incorporating pharmacogenomics
(PGx) results in clinical decisions has yet to diffuse widely. In this study, we conducted a …

Pharmacogenomic (PGx) testing is gaining recognition from physicians, pharmacists and
patients as a tool for evidence-based medication management. However, seemingly similar …

Pharmacogenomics (PGx) technology is advancing rapidly; however, clinical adoption is
lagging. The Indiana Institute of Personalized Medicine (IIPM) places a strong focus on …

Pharmacogenomic (PGx) testing has emerged as an effective strategy for informing drug
selection and dosing. This has led to an increase in the use of PGx testing in the clinic and …